Drugs Made In America Acquisition Corp
DMAAU10.370USD
0.000
終値 09/19, 16:00（ET）15分遅れの株価
0.00時価総額
--直近12ヶ月PER
詳細情報 Drugs Made In America Acquisition Corp 企業名
Drugs Made In America Acquisition Corp. is a blank check company. The Company is incorporated as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus its search for business combination targets in the pharmaceutical industry.
企業情報
企業コードDMAAU
会社名Drugs Made In America Acquisition Corp
上場日Jan 28, 2025
最高経営責任者「CEO」Ms. Lynn Stockwell
従業員数- -
証券種類Unit
決算期末- -
本社所在地1 East Broward Boulevard
都市FT LAUDERDALE
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号33301
電話番号19548703099
ウェブサイト
企業コードDMAAU
上場日Jan 28, 2025
最高経営責任者「CEO」Ms. Lynn Stockwell
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sat, May 17
更新時刻: Sat, May 17
株主統計
種類
株主統計
株主統計
比率
Drugs Made In America Acquisition LLC
17.88%
RiverNorth Capital Management LLC
1.79%
Context Capital Management LLC
1.07%
Wolverine Asset Management, LLC
0.55%
Bulldog Investors, LLP
0.24%
他の
78.46%
株主統計
株主統計
比率
Drugs Made In America Acquisition LLC
17.88%
RiverNorth Capital Management LLC
1.79%
Context Capital Management LLC
1.07%
Wolverine Asset Management, LLC
0.55%
Bulldog Investors, LLP
0.24%
他の
78.46%
種類
株主統計
比率
Corporation
17.88%
Investment Advisor/Hedge Fund
2.25%
Hedge Fund
1.68%
Research Firm
0.20%
Investment Advisor
0.08%
他の
77.91%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
20
7.49M
31.98%
+6.93M
2025Q1
20
7.60M
32.43%
+7.41M
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
RiverNorth Capital Management LLC
420.50K
1.79%
+418.00K
+16719.92%
Mar 31, 2025
Context Capital Management LLC
250.00K
1.07%
+250.00K
--
Mar 31, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
+130.00K
--
Mar 31, 2025
Bulldog Investors, LLP
130.26K
0.56%
+130.26K
--
Mar 31, 2025
Clear Street LLC
5.85K
0.03%
+5.85K
--
Mar 31, 2025
Robinson Capital Management, LLC
10.00K
0.04%
-10.00K
-50.00%
Mar 31, 2025
Tuttle Capital Management, LLC
40.00K
0.17%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
18.28K
0.08%
+18.28K
--
Mar 31, 2025
Citadel Advisors LLC
15.75K
0.07%
+15.75K
--
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
